SLC1A5 and pancreatic adenocarcinoma: For example, 60-year-old PAAD patients who are diagnosed as G2, T2, and N0 stages, with high SLC1A5 expression, will get about 165 points in total, which corresponds to a 3-year OSR of 70%.